Announcements
-
SPRAVATO™ (esketamine) FDA Approval Press Release
SPRAVATO™ (esketamine) FDA Approval Press ReleaseDate last updated: 03/06/2019 -
LEVAQUIN® (levofloxacin) Dear Healthcare Professional Letter, December 2018
LEVAQUIN® (levofloxacin) Dear Healthcare Professional Letter, December 2018Date last updated: 01/02/2019 -
SYMTUZA™ (darunavir/ cobicistat/ emtricitabine/ tenofovir alafenamide) FDA Approval Press Release
SYMTUZA™ (darunavir/ cobicistat/ emtricitabine/ tenofovir alafenamide) FDA Approval Press ReleaseDate last updated: 07/18/2018 -
Janssen Scientific Affairs, LLC announces the availability of the Population Health Management Resource Guide in partnership with NCQA
Janssen Scientific Affairs, LLC announces the availability of the Population Health Management Resource Guide in partnership with NCQADate last updated: 10/09/2018 -
OLYSIO® (simeprevir) Dear Healthcare Professional Letter
OLYSIO® (simeprevir) Dear Healthcare Professional LetterDate last updated: 05/25/2018 -
NCQA Partners with Janssen on a PHM Resource Guide for Health Care Organizations
NCQA Partners with Janssen on a PHM Resource Guide for Health Care OrganizationsDate last updated: 04/16/2018 -
DARZALEX® (daratumumab) FDA Approval Press Release
DARZALEX® (daratumumab) FDA Approval Press ReleaseDate last updated: 06/29/2018 -
ERLEADA™ (apalutamide) FDA Approval Press Release
ERLEADA™ (apalutamide) FDA Approval Press ReleaseDate last updated: 06/29/2018
